LASP1 served as a target of miR‐133a in regulating NSCLC development and miR‐133a achieved an inhibitory effect on NSCLC by suppressing TGF‐β/Smad3 signaling pathway. Here, SMAD3 is linked to non-small cell lung carcinoma.